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Abstract
Background: Single nucleotide polymorphisms (SNPs) are the most common genetic variations
in the human genome and are useful as genomic markers. Oligonucleotide SNP microarrays have
been developed for high-throughput genotyping of up to 900,000 human SNPs and have been used
widely in linkage and cancer genomics studies. We have previously used Hidden Markov Models
(HMM) to analyze SNP array data for inferring copy numbers and loss-of-heterozygosity (LOH)
from paired normal and tumor samples and unpaired tumor samples.
Results: We proposed and implemented major copy proportion (MCP) analysis of oligonucleotide
SNP array data. A HMM was constructed to infer unobserved MCP states from observed allele-
specific signals through emission and transition distributions. We used 10 K, 100 K and 250 K SNP
array datasets to compare MCP analysis with LOH and copy number analysis, and showed that
MCP performs better than LOH analysis for allelic-imbalanced chromosome regions and normal
contaminated samples. The major and minor copy alleles can also be inferred from allelic-
imbalanced regions by MCP analysis.
Conclusion:  MCP extends tumor LOH analysis to allelic imbalance analysis and supplies
complementary information to total copy numbers. MCP analysis of mixing normal and tumor
samples suggests the utility of MCP analysis of normal-contaminated tumor samples. The described
analysis and visualization methods are readily available in the user-friendly dChip software.
Background
A normal human cell has 23 pairs of chromosomes. For
each of the autosomal chromosomes (1 to 22), there are
two copies of homologous chromosomes inherited
respectively from the father and mother of an individual.
However, in a tumor cell, the copy number may be differ-
ent from two at certain chromosomal regions due to dele-
tion and amplification events. Loss of the contribution of
one parent in selected chromosome regions can also hap-
pen due to hemizygous deletion or mitotic gene conver-
sion (termed loss of heterozygosity or LOH). When such
alterations affect tumor-suppressor genes (TSG) or onco-
genes and confer growth advantage to cells, they will be
selected in descendant cells and contribute to cancer for-
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mation [1]. Identifying such abnormal copy number and
LOH regions in tumor samples may thus help to identify
cancer-related genes and provide clues about cancer initi-
ation or growth [2,3].
Single nucleotide polymorphisms (SNP) are the most
common genetic variations in the human genome. Oligo-
nucleotide SNP microarrays have been developed for
high-throughput genotyping of up to 900,000 human
SNPs [4,5]. They contain probe sequences complemen-
tary to the DNA sequences surrounding the interrogated
SNPs. The genomic DNA is amplified, fragmented and
labeled, and then hybridized to a SNP array. The scanned
array images are analyzed to obtain the genotype calls of
all the interrogated SNPs at a high accuracy (>99.3%) [6].
Compared with other experimental techniques, SNP
arrays have high throughput and high marker resolution,
and they require small amount of DNA per sample (250
ng). They have been utilized in linkage and association
studies to identify disease genes [7,8] and in genomics
studies to identify LOH and copy number alterations in
cancer samples and copy number variation in normal
samples [9-11].
The initial methods for analyzing cancer samples using
SNP arrays perform copy number and LOH analysis sepa-
rately [10,12], so each analysis yields genomic alteration
information that another analysis may not provide.
Recently, allele-specific and parent-specific copy numbers
have been developed to utilize allele-specific signals
obtained from SNP arrays [13-15]. Allele-specific copy
numbers (ASCN) can be estimated from allelic signals at
heterozygous SNPs. However, a pair of copy numbers is
not straightforward to summarize across multiple samples
into a single statistic indicating the excess of genomic
alterations. In addition, Hidden Markov Models (HMM)
that can successfully smooth total copy number or LOH
do not work as efficiently on allele-specific copy numbers
due to large number of ASCN states for a pair of copy
numbers. In this paper, we defined major copy propor-
tion as a quantity that contains the information difference
between the total copy number and ASCN at a locus, and
used a HMM algorithm to estimate it from allelic signals.
We used 10 K, 100 K and 250 K SNP datasets to demon-
strate the method performance and compare it to LOH
and copy number analysis.
Results and Discussion
Definition of major copy proportion
The major copy proportion (MCP) of a SNP is defined as
C2/(C1 + C2), where C1 and C2 are the parental copy num-
bers at this SNP in a sample and C1 ≤ C2. The value of MCP
is between 0.5 and 1 by definition, with various values
corresponding to different relative proportions of parental
copy numbers. The MCP is 0.5 for normal loci or balanced
copy alterations, 1 for LOH, and a value between 0.5 and
1 for allelic imbalanced copy number alterations. MCP
therefore quantifies allelic imbalance and is a natural
extension of LOH analysis. MCP and total copy number
(C1 + C2) together provide the same amount of informa-
tion as allele-specific copy numbers, while each of them is
a scalar quantity that can be more efficiently estimated
and conveniently used in downstream analysis.
We describe here two examples that can benefit from esti-
mating MCP values. First, normal sample contamination
in tumors often leads to conservative "No Call" genotypes
and intervening LOH or retention calls (see below for spe-
cific examples). MCP can better quantify the proportion
of normal sample contamination while still identify
allelic-imbalanced regions due to LOH. Second, tumors
with hyperploidy often contain allelic-imbalanced
regions with both parental alleles kept. If the total copy
number in such regions is close to the cell ploidy, copy
number analysis will reveal a normal relative copy and
LOH analysis will show retention. However ASCN or
MCP analysis can discover allelic-imbalance as genomic
alteration in such regions.
Hidden Markov Model for estimating MCP
SNP-based LOH or copy number data along a chromo-
some are locally correlated and HMM is an effective ana-
lytic method for such data structure. HMMs have been
utilized to analyze array-based copy number changes
[12,16-21] and to infer LOH from unpaired tumor sam-
ples [22]. Here we used a similar HMM for the MCP infer-
ence.
The normalized probe intensity values (Figure 1) were
used to compute allele-specific SNP signals and raw copy
numbers (see "Methods"). We then used HMM to model
the MCP correlation of neighboring SNPs on a chromo-
some. The MCP values to be inferred are between the
range of 0.5 to 1 and have 11 states under the default
increasing step of 0.05 (comparable to the noise level in
our data). The observed data is the raw allele A proportion
(RAP), defined as RA/(RA + RB), where RA and RB are the
raw allelic copy numbers of the two genotype alleles (A
and B) at a SNP. For a heterozygous SNP in a sample, RAP
should vary by a certain noise level around the unob-
served MCP (when A is the major copy allele) or 1 – MCP
(when A is the minor copy allele); for a homozygous SNP,
RAP is close to 1 for genotype AA and close to 0 for geno-
type BB, since one of RA and RB is close to 0. These consid-
erations motivate the function form of the HMM emission
distribution (see "Methods").
The HMM with emission and transition distributions
specify the joint probability of the unobserved MCP and
the observed RAP of all SNPs in a chromosome of a sam-BMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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ple. The Viterbi algorithm [23] was then used to obtain
the most probable MCP state path as the inferred MCP
values. The procedure was run separately for all chromo-
somes and all samples in a dataset.
Datasets used
We used several SNP array datasets to illustrate the analy-
sis and visualization methods and to compare the results.
(1) 10 K SNP dataset. Zhao et al. [12,24] generated Early
Access 10 K SNP array data for 14 breast and lung carci-
noma cell lines and their paired normal cell lines, as well
The probe level data of one SNP Figure 1
The probe level data of one SNP. (A) Left: The SNP has 20 probe pairs, whose normalized intensity values in one array 
are displayed and connected in blue (perfect match or PM) and gray (mismatch or MM) lines. The probe set has probe pairs for 
both A and B alleles and for the forward and reverse DNA strand. Right: The same probes are displayed in a brightness scale, 
with the matching A and B probe pairs in the same column. The SNP genotype is called as AB in this sample. (B) The probe 
data of the same SNP in another sample with genotype AA. (C) The probe data of the SNP in a third sample with genotype 
AA. However, the probe signals here are about one half as those in B, presumably corresponding to hemizygous deletion at 
this SNP position.
A
B
CBMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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as 4 primary lung carcinomas and their paired normals.
The array contains 10,043 SNPs with an average resolu-
tion of 300 kb. This work is one of the first demonstra-
tions of combined copy number and LOH analysis using
SNP arrays. (2) 100 K SNP dataset. Zhao et al. [25,26] gen-
erated 100 K SNP array data for 70 primary human lung
carcinoma specimens and 31 cell lines derived from
human lung carcinomas. 12 unpaired normal samples
were used as reference in copy number analysis. The array
contains 115,593 SNP with an average resolution of 24
kb. LaFramboise et al. [13] further analyzed this dataset to
develop allele-specific copy number analysis and gener-
ated allele-specific quantitative PCR (Q-PCR) measure-
ments for selected loci to compare allele-specific copy
numbers from Q-PCR and SNP arrays. (3) 250 K cell line
dataset. Affymetrix has made freely available a 500 K (con-
sisting two 250 K SNP arrays) SNP dataset consisting of 9
tumor/normal pairs derived from breast and lung cancer
cell line [27]. The average marker resolution is 5.8 kb and
85% of the human genome is within 10 kb of a SNP. In
this work we used the subset of the 250 K STY array data.
(4) 250 K lung tumor dataset. Weir et al. [28] generated
250 K STY SNP array data for 371 primary lung adenocar-
cinomas and 242 matched normal samples. We used a
subset of 45 pairs of normal and tumor samples that are
publicly available [29].
Visualizing MCP
The dChip software [30,31] was used to implement the
methods and visualize the analysis results. Figure 2 com-
pares the observed LOH view in dChip with the new MCP
view using the chromosome 7 of the 10 K SNP dataset. In
the MCP view (Figure 2B), different shades of gray corre-
spond to MCP values greater than 0.5, highlighting allelic
imbalanced regions. Comparing to the raw LOH calls on
the left, MCP discovers more allelic-imbalanced regions
The LOH and MCP data views of a chromosome Figure 2
The LOH and MCP data views of a chromosome. The tumor samples are displayed on columns and the SNPs are 
ordered on rows by their chromosome positions. (A) Observed LOH calls by comparing normal (N) and tumor (T) genotypes 
at the same SNP. Yellow: retention (AB in both N and T), Blue: LOH (AB in N, AA or BB in T), Red: Conflict (AA/BB in N, BB/
AA or AB in T), Gray: Non-informative (AA/BB in both N and T), White: No Call (No Call in N or T). (B) In the inferred MCP 
data view, the white and gray colors represent inferred MCP levels from 0.5 to 1 according to the color scale. When the 
inferred major copy allele is estimated to be different from the minor copy allele at a SNP (see "Methods"), the SNP position is 
colored in red or blue according to the major copy allele (A or B).
ABBMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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that could cause excessive No Calls (sample H128t) or
intervening LOH and retention calls (sample 57588T) in
genotype-based LOH analysis.
In another example, we compared different SNP data
views of a lung cancer cell line with paired normal (sam-
ple H1395 from the 10 K dataset). The most interesting
region in chromosome 18 is indicated by braces in Figure
3. The tumor sample contains many No Call genotypes in
this region (white colors in Figure 3C), and the paired
LOH analysis yields intervening retention, LOH and No
Calls (Figure 3A). The raw copy numbers of this region
center around ploidy or the relative copy number 2 (Fig-
ure 3B). The raw major allele proportion curve in Figure
3C reveals that most values are either close to 1 (corre-
sponding to homozygous SNPs) or between 0.6 and 0.7.
A likely explanation for these data is that this chromo-
some region has three copies and the whole genome is
near triploid, which is confirmed by spectral karyotyping
data [32]. Two copies of this region are from one parent
and one copy is from another, creating underlying MCP of
two thirds (0.67), close to the inferred MCP value of 0.65
The LOH, copy number, genotype and MCP data views of chromosome 18 of sample H1395t Figure 3
The LOH, copy number, genotype and MCP data views of chromosome 18 of sample H1395t. (A) LOH from 
paired analysis, similar to Figure 2A. (B) Raw copy numbers. (C) Genotype calls. The red, yellow, blue and white colors repre-
sent genotype AA, AB, BB and No Call. (D) Inferred MCP, similar to Figure 2B. The blue curves displayed on the right in the 
gray boxes represent: (A) inferred LOH probability, (B) raw copy number, (C) raw major allele proportion (MAP), computed 
as Max(RA, RB)/(RA + RB), and (D) inferred MCP. Comparing the two curve in C and D, we can visually assess how the HMM 
infers MCP at regions of mixed homozygous and heterozygous genotypes.
A B                    C                     DBMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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(blue curve in Figure 3D). Interestingly, the chromosome
region below this region has retention of heterozygosity,
a MCP of 0.5, but copy numbers below ploidy (indicated
by arrow in Figure 3). This region most likely has one copy
of each parental chromosome, creating copy number
decrease from ploidy while retaining the heterozygosity.
Therefore, genotype-based LOH analysis suggests the mid-
dle region in Figure 3 to be unusual, but the MCP analysis
helps to pinpoint the underlying cause of the abnormal-
ity. The MCP result also reveals that the heterozygous
SNPs in this region have real genotype AAB or ABB. The
standard genotyping algorithm are trained by normal
samples [6,33], thus making conservative No Call or
incorrect AB or AA/BB call for these complex genotypes
and leading to intervening LOH, retention or No Calls in
genotype-based LOH analysis. Combining MCP and total
copy number, we can thus obtain a more complete under-
standing of the genomic structure of tumor samples.
Comparing MCP and LOH
We then used 18 pairs of normal and tumor samples in
the 10 K dataset to compare the paired LOH and MCP
analysis. 14 of these pairs are normal and tumor cell line
samples. SNPs were classified as LOH or retention SNPs
based on paired LOH analysis (Figure 2A) and then com-
pared with their MCP values. Figure 4A orders these tumor
samples by their increasing sample-wise LOH rates (1.2%
to 75%, curve 1). In all the samples, more than 90% LOH
SNPs have MCP ≥ 0.6 (curve 2); in all but two samples,
more than 80% LOH SNPs have MCP ≥ 0.9 (curve 3). The
two samples 83437 and 57588 both have LOH rate below
20% and most of their LOH SNPs are in the intervening
LOH and retention regions (the last two columns of Fig-
ure 2A). MCP values between 0.6 and 0.9 correctly identi-
fied these regions as allelic imbalance rather than LOH. In
fact, these two samples are primary tumor samples and
could contain normal sample contamination [12], which
likely cause most LOH areas in pure tumor cells to
Comparing LOH and MCP from paired analysis Figure 4
Comparing LOH and MCP from paired analysis. The samples are ordered on the X-axis by their sample LOH percent-
age from paired LOH analysis. (A) 10 K SNP data. (B) 250 K cell line data. (C) 250 K lung tumor data, where the sample names 
are omitted.
0
20
40
60
80
100
120
CRL-
2338D
CRL-
5868D
CRL-
2340D
CRL-
2314D
CRL-
2320D
CCL-
256D
CRL-
2321D
CRL-
2324D
CRL-
2336D
0
20
40
60
80
100
120
8
3
4
3
7
H
C
C
2
2
1
8
5
7
5
8
8
1
8
2
5
2
H
2
1
0
7
H
C
C
1
5
9
9
H
2
1
4
1
H
1
3
9
5
H
1
6
4
8
H
2
1
7
1
H
2
8
9
H
C
C
3
8
H
1
2
8
H
C
C
1
0
0
7
H
C
C
1
1
8
7
H
C
C
1
1
4
3
H
C
C
1
3
9
5
H
C
C
1
9
3
7
(1) Sample LOH %
(2) % of MCP  0.6 at SNPs called LOH
(3) % of MCP  0.9 at SNPs called LOH
(4) % of MCP  0.6 at SNPs called retention
(5) % of MCP  0.9 at SNPs called retention
A 
BC
0
20
40
60
80
100
120BMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
Page 7 of 16
(page number not for citation purposes)
become allelic imbalance in the normal-contaminated
tumor samples. In contrast to the LOH SNPs, the reten-
tion SNPs seldom have MCP value ≥ 0.9 in all the samples
(curve 5), although in many samples more than 20% of
the retention SNPs have MCP value ≥ 0.6 (curve 4). These
regions often have copy number alterations that cause
allelic imbalance but not LOH, leading to intervening
retention and LOH calls (the last three columns of Figure
2A).
We also made similar comparison using the two 250 K
datasets. Figure 4B shows the same percentages as Figure
4A for the 250 K cell line dataset of 9 sample pairs. All per-
centages have similar performance as the 10 K data. The
percent of MCP ≥ 0.9 at paired LOH calls (curve 3) is low
at the sample CRL-2338D. Inspecting the paired LOH
calls in this sample reveals that most LOH in them are
intervened with retention calls (Figure 5A), indicating
allelic-imbalance rather than LOH. In contrast, the MCP
analysis inferred smooth and moderate MCP values in
this sample (Figure 5B), better discovering the underlying
genomic alterations. Figure 4C shows the same compari-
son percentages for the 250 K lung primary tumor dataset
of 45 sample pairs. All samples except one have paired
LOH call percentage below 20% (curve 1). This can be due
that the LOH events are at a lower frequency in these pri-
mary tumors or that the homozygous genotypes in LOH
regions of tumor cells are masked by normal sample con-
tamination up to 30% [28]. The portions of MCP ≥ 0.6
among paired LOH or retention calls both drop as paired
LOH percentage drops (curve 2 and 4), while the portions
of MCP ≥ 0.9 among paired LOH are near zero for all sam-
ples (curve 3, which overlays with curve 5), supporting the
existence of normal sample contamination in most sam-
ples.
In summary, MCP analysis is able to discover real LOH
and retention events. It also discriminates allelic-imbal-
anced regions from LOH through intermediate MCP val-
ues between 0.5 and 1, instead of yielding intervening
LOH and retention calls.
Comparing MCP and copy numbers
It is of interest in cancer research whether copy number
gains or amplifications are allelic-balanced or imbalanced
events, since the genes in the imbalanced events could
have a variant or mutant form preferentially amplified
[13]. SNP arrays have the advantage of providing both
allelic-imbalance and copy number information. We have
previously used the 10 K dataset to show that the LOH
events can involve copy number deletion, copy-neutral or
amplification events, while retention mostly occur at
copy-neutral or amplification events [22]. With the
inferred MCP as the extension of LOH calls, we now ask
how allelic imbalanced events correlate with copy num-
bers. A visual comparison of LOH, MCP and copy number
using the 250 K cell line dataset is in Figure 5. In the p-arm
of sample CRL-2324D, LOH events correspond to both
copy number amplifications and deletions.
We then stratified SNPs by copy number bins and com-
puted the distribution of MCP values at various copy
numbers. In the 10 K data (mostly cell lines, Figure 6A)
and the 250 K cell line data (Figure 6B), the copy numbers
below 1.5 mostly correspond to MCP values ≥ 0.95 (LOH
or extreme allelic imbalance). As copy number increases,
the percent of "MCP ≥ 0.95" decreases while the percent
of "MCP ≤ 0.6" (retention or near allelic balance)
increases, indicating that larger copy number gains or
amplifications involve less frequently with LOH and more
frequently with allelic balanced and imbalanced events.
In both 10 K and 250 K cell line data, there is a noticeable
drop of allelic-balanced events ("MCP ≤ 0.6") around
copy number of 3. The fact that 3 copies can have bal-
anced amplifications is due to that the copy numbers
from SNP arrays are not absolute copy numbers but rela-
tive to the ploidy of tumor cells (see "Methods"). Simi-
larly, there are SNPs with MCP values close to 0.5 but copy
number below 1, since in hyper-diploid samples the real
copy number 2 has array-based relative copy number
below 2. The peak at copy number 0.4 in Figure 6A is
likely due to the small sample variation (4 of 39 data
points at the copy bin 0.4 have MCP of 0.5) or inaccu-
rately inferred MCP values.
In contrast, different patterns emerge from the 250 K
tumor dataset (Figure 6C). The percent of "MCP ≥ 0.95" is
nearly zero at all copy numbers, and the portion of allelic-
balanced events has a single peak around copy number of
2 and drops rapidly as copy number goes lower or higher.
These could be explained by potentially prevalent normal
sample contamination in these primary tumors, which
could cause the attenuation of aberrant copy number val-
ues toward the normal copy of 2, as well as make the LOH
or allelic-imbalanced amplification events in tumor cells
to appear less allelic-imbalanced in contaminated tumor,
leading to high percent of MCP values between 0.55 and
0.75.
Next we used the 100 K SNP array dataset with allele-spe-
cific copy numbers measured by quantitative PCR (Q-
PCR) to compare the MCP based on SNP arrays and Q-
PCR. We used the same SNPs to design the primers for Q-
PCR and to obtain their array-based signals for compari-
son. Since Q-PCR measures allele-specific copy numbers
rather than parent-specific copy numbers, we defined
major allele proportion (MAP) as Max(A, B)/(A + B) and
used it in the comparison, where A and B are Q-PCR or
array-based allelic copy numbers. Table 1 shows that most
array-based MCP and the Q-PCR-based MAP values agreeBMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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within a difference of 0.15 ("PCR MAP" and "Array MCP"
columns). The largest difference of 0.44 (bold values in
the table) occurs at SNP 589797 in sample S0515T. This
SNP has homozygous genotype in the sample (both PCR
and array-based MAP values are close to 1), but its multi-
ple neighboring SNPs have heterozygous genotypes and
MAP values close to 0.5 (data not shown), which contrib-
utes to the final inference of MCP 0.55 at the SNP 589797.
Together with an amplified total copy number, we con-
clude that the DNA at the SNP is about equally amplified
for both parental alleles.
MCP analysis of normal contaminated samples
We next checked how well MCP can address two chal-
lenges of applying SNP arrays in cancer genomics: tumor
samples frequently lack paired normal samples to per-
The LOH, MCP and copy number data of chromosome 1 of the 250 K cell line data Figure 5
The LOH, MCP and copy number data of chromosome 1 of the 250 K cell line data. (A) The LOH calls from paired 
normal and tumor analysis. (B) The inferred MCP values. (C) The copy number of tumor samples is displayed in log2 ratio scale 
relative to the normal copy of 2.
A B C                     BMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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form paired LOH or MCP analysis, and tumor tissue sam-
ples often contain normal stromal cell contamination.
The HMM emission distributions can flexibly use either
paired normal genotypes in paired MCP analysis or pop-
ulation-based normal genotype distribution in tumor-
only analysis (see "Methods"). We checked how well the
MCP estimated using paired normal and tumor samples
agree with the MCP estimated using only tumor samples.
In the 10 K dataset, the sample-wise absolute MCP differ-
ences between the two methods in the 18 samples range
from 0.0006 to 0.025, and the sample-wise standard devi-
ations of the MCP differences range from 0.013 to 0.075.
In the 250 K lung tumor dataset, these two differences
measures are larger across the 45 tumors, ranging from
0.011 to 0.041 and 0.050 to 0.114 respectively. Visual
inspection of the MCP inferred from the 250 K data
reveals many small regions that have MCP value ≥ 0.5 in
tumor-only analysis but have MCP value of 0.5 in paired
analysis. They are caused by stretches of homozygous gen-
otypes that are in linkage disequilibrium, in a similar way
as the false positives in tumor-only LOH analysis [22]. By
utilizing the genotype dependence of neighboring 5 SNPs
in the HMM emission probabilities of tumor-only MCP
analysis (see "Methods"), the two differences measures
are smaller (ranges are 0.0001 – 0.026 and 0.008 –
0.097). Overall the differences between paired and tumor-
only MCP inferences are fairly small compared to the val-
ues that MCP can take (0.5 to 1).
Stratifying MCP according to copy numbers Figure 6
Stratifying MCP according to copy numbers. The 5-SNP smoothed copy numbers were scaled to have mode at two cop-
ies for each sample, and then were binned into copy number intervals of a width of 0.2. For example, on the X-axis, 0 indicates 
the copy number bin [0, 0.2] and 2 indicates the copy number bin [2, 2.2]. The cumulative percentages of MCP for the SNPs in 
a particular copy number bin were displayed on the Y-axis, using all cell line or tumor samples of the 10 K data (A), 250 K cell 
line data (B), and 250 K lung tumor data (C). In Figure C, the copy interval 0 and 0.2 are not plotted since there are fewer than 
20 data points to compute percentages.
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We next asked how much the tumor-only MCP method is
tolerant to normal contamination. The 10 K dataset con-
tains a mixing experiment of paired normal and tumor
samples [12]. A tumor cell line (HCC38t) was mixed with
its paired normal cell line (HCC38) at various propor-
tions and then hybridized to 10 K SNP arrays. In Figure 7,
sample HCC38M9 to HCC38M6 are mixture samples
with tumor content of 90%, 80%, 70% and 60% respec-
tively. The LOH regions in the pure tumor sample should
become allelic-imbalanced regions in the mixture sam-
ples. Figure 7 shows a typical example of inferred LOH
and MCP data using unpaired analysis (paired analysis for
the column labeled with "HCC38t" in blue color). Com-
pared to the LOH data (Figure 7A), MCP analysis better
identified the boundaries of the allelic-imbalanced
regions in all the mixture samples (Figure 7B). The values
of estimated MCP for the LOH regions are less than 1 in
the mixture samples (Figure 7C), corresponding to allelic-
imbalance created by normal sample contamination.
Interestingly, both LOH and MCP analysis performs bet-
ter for the bottom LOH region than the top LOH region in
the mixture samples, due to copy-neutral LOH in the bot-
tom region and hemizygous deletion in the top region
(copy number data not shown).
Figure 8 shows the whole-genome MCP values inferred
for paired analysis (column 1) and for tumor-only analy-
sis of tumor (column 2) and mixture samples (column
3–6). The MCP patterns largely preserve but MCP values
attenuate toward 0.5 as tumor content decreases. If a
threshold of "MCP ≥ 0.6" is used to call allele-imbalanced
SNPs (red vertical line in the shaded boxes) and we regard
paired MCP analysis as the ground truth, at tumor content
of 80% (column 4) we could achieve 88.5% for sensitivity
and 88.2% for specificity. But at tumor content of 70%
(column 5) the sensitivity and specificity dropped to
82.6% and 60.4%. This shows that normal contamination
of up to 20% is tolerable when calling allele-imbalanced
regions in MCP analysis.
Major and minor copy alleles
One feature of the MCP algorithm is that it also infers the
major and minor copy alleles for SNPs that are hetero-
zygous in normal sample and undergo LOH or allele-
imbalance in tumor (see "Methods"). In Figure 7B, a SNP
is colored in red or blue for major copy allele A or B if its
major copy allele (MCA) can be inferred and is different
from the minor copy allele, which is not displayed. In the
paired MCP analysis (Figure 7B, column "HCC38t" with
blue color), the MCA is inferred to be different from
minor copy allele for many SNPs since the normal sample
contains information on heterozygous SNPs and LOH in
the tumor sample provides information on the kept allele
as MCA. In contrast, in the tumor-only MCP analysis (Fig-
ure 7B, column "HCC38t" with black color), we can infer
two regions of LOH (MCP is 1) as well as MCA, but there
is no information on minor copy allele, so no SNP is
colored. However, as normal contamination increases
from sample HCC38M9 to HCC38M6, the minor copy
allele of more and more SNPs can be estimated from the
mixing normal sample, so more SNPs are colored to indi-
cate MCA is different from minor copy allele (Figure 7B).
These results show that allelic-imbalances (such as those
in the mixture samples) can help to distinguish major and
Table 1: Comparison of MCP based on SNP arrays and major allele proportions (MAP, Max(A, B)./(A+B)) based on allele-specific Q-
PCR or array-based allelic signals. 
Sample SNP Chromo-
some
Position(Mb
)
PCR allele A 
Copy
PCR allele B 
Copy
PCR MAP Array MAP Array MCP Array Copy
S0465T 189422
8
3 183.975 25.18 1.68 0.94 0.86 0.8 4.8
S0515T 189407
5
3 183.786 2.42 38.37 0.94 0.65 0.8 17.47
HCC827 256869
0
7 54.606 135.92 1.97 0.99 0.82 0.8 8.07
H2087 280496
2
8 128.906 1.23 6.03 0.83 0.74 0.7 6.05
H2122 280422
8
8 128.037 58.46 3.39 0.95 0.98 0.95 6.55
HCC827 280464
6
8 128.332 0.06 7.58 0.99 0.9 0.95 9.39
S0515T 589797 12 32.822 0.06 7.12 0.99 0.96 0.55 4.32
H2087 590880 12 33.8 17.32 0.03 1 0.88 0.95 10.42
H2087 611421 12 57.198 4.86 0.17 0.97 0.95 0.8 11.3
HCC135
9
167984
3
22 19.774 1.03 8.36 0.89 0.82 0.9 8.74
Both SNP arrays and Q-PCR yield allelic-specific copy numbers relative to sample ploidy. "Array Copy" is the array-based total copy number by 
median smoothing of raw copy numbers with a window size of 5 SNPs. The chromosome positions are based on the UCSC hg16 genome assembly.BMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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minor copy alleles, while LOH or allelic-balanced events
can not.
Therefore in tumor-only MCP analysis, normal contami-
nation at low percentage (≤ 20%) can be turned beneficial
through MCP analysis. The normal contaminated samples
contain the information of both normal sample geno-
types and tumor genome alterations (LOH and copy
number changes). In the tumor-only MCP analysis, the
normal genotype information is utilized in the form of
Comparing LOH and MCP using the 10 K mixing samples Figure 7
Comparing LOH and MCP using the 10 K mixing samples. The inferred LOH (A) and MCP (B, C) are displayed for 
chromosome 4. In the tumor-only LOH inference (the columns except column 1 in A), the inferred probability of LOH is dis-
played using a blue (1 – 0.5) to white (0.5) to yellow (0.5 – 0) color scale. See legends of Figure 2 for additional color schemes.
A B                    C                     BMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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allele-specific raw copy numbers in the HMM emission
distributions (see "Methods"). As the result, the allele-
imbalanced regions are identified in a similar way to
paired LOH analysis via normal-tumor genotype compar-
ison rather than tumor-only LOH inference, which resorts
to unrelated reference normal genotypes to distinguish
between LOH and homozygous haplotype blocks [22].
The normal contaminated samples also help to provide
information on both major and minor copy allele at
allelic-imbalanced regions, which can be useful in down-
stream analysis. If the contamination percentage can be
estimated by other experimental measures, the inferred
MCP or copy number from normal contaminated samples
can be adjusted proportionally to obtain the MCP/LOH
and copy number values of the unavailable pure tumor
samples. However, efforts should be made to obtain pure
tumor samples and their paired normals for separate
hybridization whenever possible, as paired MCP analysis
can better recover allele-imbalance information than
tumor-only MCP analysis of contaminated samples (Fig-
ure 8).
The genome-wide view of inferred MCP in the mixture samples Figure 8
The genome-wide view of inferred MCP in the mixture samples. The red vertical lines in the gray boxes represent a 
MCP threshold of 0.6. See the legend of Figure 2B and 3D for color schemes.
1       2        3        4        5        6BMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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Downstream analysis and related analysis methods
MCP is an extension of LOH and contains complementary
information to total copy numbers. Similar to LOH and
copy number analysis of a set of tumor samples, a MCP
summary score for each SNP may be computed across
samples, such as the average MCP value across all sam-
ples. Then the chromosome regions can be permuted
within samples, and the MCP scores computed from the
permuted data can be compared to the original MCP
scores to assess the significance of the latter [34]. A com-
posite alteration score using both MCP and total copy
number may also be used, such as the proportion of sam-
ples with copy > 3 and MCP > 0.65 to capture only allelic
imbalanced amplifications.
There are several allele-specific copy number (ASCN)
analysis methods for SNP arrays [13,14,16,35]. While
total copy number plus MCP provide the same amount of
information as allele-specific copy numbers, MCP extends
the LOH analysis in a natural way and offers a univariate
statistic to capture both LOH and allele-imbalance events.
Such univariate quantity is more efficiently estimated and
easily used in downstream analyses than a pair of allelic
copy numbers. If needed, the total copy number and MCP
can be combined to be equal to the analysis using allelic-
specific copy numbers. The MCP analysis also reports
major and minor copy alleles for allelic comparisons in
allele-imbalanced regions. Several of the above ASCN
methods also use probe sequence and restriction fragment
length to adjust for probe signals to improve signal to
noise ratios. Such adjusted raw allelic copy numbers can
be conveniently used as the input of the MCP analysis
through the dChip software.
Similar to all copy number analysis of SNP arrays, ideally
we need paired normal samples for MCP analysis. When
such paired samples are not available and an independent
set of normal samples are used for reference signals, copy
number variations (CNV) in normal samples may con-
found tumor copy number analysis [36,37]. To address
this issue, we have implemented a trimming method. Spe-
cifically, we assumed that in reference normal samples, for
any SNP at most a certain percent (such as 10%) of the
samples have abnormal copy numbers. Then for each
SNP, 5% of samples with extreme signals are trimmed
from the high and low end of the raw signal distribution
and the rest samples are used to compute the signal mean
and standard deviations of normal copy numbers at the
SNP. This trimming method is designed to accommodate
a small amount of CNVs in reference normal samples and
has proven useful in copy number analysis with unpaired
or limited number of normal samples. The same trim-
ming method can be used to obtain raw allele-specific
copy numbers in the MCP analysis.
Conclusion
In this paper, we have focused on allelic imbalance analy-
sis of tumor samples using SNP arrays. We proposed to
estimate major copy proportion, which is an extension of
LOH analysis and complements total copy number anal-
ysis. HMM is used to bridge unobserved states (MCP) and
observed data (allele specific signals) through emission
and transition distributions. We compared the inferred
MCP with LOH and copy number analysis and demon-
strated that MCP performs better than LOH analysis in
allelic-imbalanced regions and normal contaminated
samples. The major and minor copy alleles can also be
inferred at allelic-imbalanced regions by MCP analysis.
The described analysis and visualization methods are
readily available in the dChip software.
Methods
Computing allele-specific raw copy numbers
We use the Invariant Set Normalization method to nor-
malize all the arrays at the probe intensity level to a base-
line array with moderate overall intensity [38]. Due to the
fact that same amount of DNA sample are hybridized
onto arrays and the normalization procedure, the total
copy numbers estimated from SNP arrays are relative to
sample ploidy. However, the inferred MCP estimates the
real MCP in tumor cells, since hybridization and normal-
ization affect the raw signals of both alleles proportion-
ally. We then computed the allele-specific signals for each
SNP and sample by applying the PM/MM difference
model [39] separately to the probe-level data of A alleles
and B alleles of all samples at a SNP probe set (Figure 1).
To obtain allele-specific raw copy numbers for a SNP, the
allele-specific signal values of all normal samples (usually
≥ 10, e.g. [16]) in a dataset and their genotypes are first
used to estimate allele-specific signal distribution. Specif-
ically, for each SNP, the A allele signal of a genotype AB or
half of the A allele signal of a genotype AA are regarded as
sample data points from the signal distribution of one
copy of A allele and are used to estimate the mean and
standard deviation of this distribution. The similar is
done for the B allele's signal distribution. When there are
fewer than six observed data points to estimate the allele-
specific distributions, the total signal (sum of A and B
allele signals) of all normal samples will be used to con-
struct allele-independent distribution of one copy [12]
and used in place of allele-specific distributions. Finally,
the allele-specific signals and standard deviations are
divided by the allele-specific means to obtain the allele-
specific raw copy numbers (RA and RB) and the standard
deviation of copy number one (StdA and StdB) for each
SNP.BMC Bioinformatics 2008, 9:204 http://www.biomedcentral.com/1471-2105/9/204
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HMM transition distribution
The transition probability specifies the probability of
changing from the MCP state at one SNP (denoted by
MCP1) to the MCP state at the next adjacent SNP (denoted
by MCP2). Similar to the LOH and copy number HMM
[12,22], we assumed that MCP changes are caused by
genetic recombination events and close SNP markers are
more likely to have the same MCP, and used the Hal-
dane's map function θ = (1 - e-2D)/2 [40] to convert the
chromosomal distance D (in the unit of 100 Mb ≈ 1 Mor-
gan) between two SNPs to the probability 2θ (denoted by
P0) that MCP2 will return to the background MCP distri-
bution in this sample and thus independent of MCP1. The
background MCP probabilities (Pb) are set non-informa-
tively to be 0.9 for MCP of 0.5 (normal locus) and 0.1/N
for the rest N MCP states. The transition probabilities are
thus:
P(MCP2|MCP1) = P0 × Pb(MCP2) if MCP1 ≠ MCP2
(1-P0) + P0 × Pb(MCP1) if MCP1 = MCP2.
Although Haldane's map function is traditionally used in
linkage analysis to describe meiotic crossover events, the
motivations of applying it here are that allelic-imbalance
or copy number changes can be caused by mitotic recom-
bination events, and mitotic recombination events may
share similar initiation mechanisms and hot spots with
the meiotic crossover events [41].
HMM emission distribution
The emission distribution specifies the probability or den-
sity of the observed RAP (raw allele A proportion, defined
as RA/(RA + RB)) given the unobserved MCP of a SNP in a
sample. If the ordered genotype alleles (G1, G2) for the
minor and major parental copy in normal sample (paired
or unavailable) are known, the function relating RAP to
MCP and ordered genotype is:
For example, if the ordered genotype is (A, B) and MCP is
0.5 (a normal locus), then RAP should have a mean of 0.5;
if the ordered genotype is (A, A) and MCP is 0.66 (e.g. one
parental chromosome has 1 copy and another has 2 cop-
ies), then RAP has mean of 1 since both parental alleles
have genotype A. The standard deviation of RAP (σ) has
default value of 0.1, which was chosen based on empirical
observation of noise level from data.
In practice, the ordered normal genotypes are only par-
tially known in paired normal samples (as unordered gen-
otypes) or unavailable in tumor-only samples. We
averaged all the four possibilities of ordered genotype in
Equation 1 to obtain the emission density function:
where  ϕ  is the standard normal density function and
P(G1, G2) is the probability of a ordered genotype. When
the paired normal sample is available, we let P(G1, G2) be
determined mainly by the observed normal genotypes
and the genotyping error rate e (default value 0.01): P(A,
A), P(A, B), P(B, A) and P(B, B) will be {1 - e, e/4, e/4, e/
2} for observed genotype AA, {e/2, e/4, e/4, 1 - e} for BB,
and {e/2, (1 - e)/2, (1 - e)/2, e/2} for AB. This in effect
compares the RAP in a tumor sample to the genotype of
the paired normal, and is similar to the LOH analysis of
paired normal and tumor samples. When the paired nor-
mal sample is not available, we used the normal samples
in the dataset or an independent reference set of normal
samples in the same ethnic group to estimate the proba-
bility of AA, BB and AB genotypes and then convert them
to P(G1, G2) similar to the above. This is effect similar to
the basic HMM for tumor-only LOH inference [22]. The
emission distribution through P(G1, G2) can also be flex-
ibly extended to consider haplotype dependence of SNPs,
which can cause long stretch of homozygous SNP geno-
types in retention regions. Similar to LD-HMM in tumor-
only LOH analysis [22], we used adjacent N SNPs in a
tumor sample to estimate the genotype distribution of a
SNP in the unavailable normal sample to improve the
estimation of haplotype dependence.
Inferring major and minor copy allele
We modified the above HMM for inferring MCP to infer
the ordered genotypes (G1, G2), where G1 is minor copy
allele and G2 is major copy allele. Specifically, the inferred
MCP is regarded as known data, so the posterior probabil-
ity (PG) of different (G1, G2) can be compared and the one
with the largest PG is regarded as the inferred ordered gen-
otype:
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SNP (Single Nucleotide Polymorphism), LOH (Loss-of-
Heterozygosity), CGH (Comparative Genomic Hybridiza-
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copy proportion), MCA (Major copy allele), RAP (raw
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